Treating children and adolescents. Regarding the pharmacological
treatment of anxiety disorders, experience
in children and adolescents suggests that SSRIs
should be the fi rst-line treatment. However, there
have been warnings against their use due to concerns
about increased risk of suicidal ideation and behavior.
Careful monitoring is advisable, due to possible
diagnostic uncertainty and the presence of comorbid
depression.